Hormonal Contraceptives Market Trends

Skyquest Technology's expert advisors have carried out comprehensive research on the hormonal contraceptives market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.

Hormonal Contraceptives Market Dynamics

Hormonal Contraceptives Market Drivers

Increasing Awareness about family planning and women’s education

  • The increase in awareness about family planning, coupled with rising female education levels are one of the key factors for the growth of the market. The Family Planning 2030 (FP2030) aims to enable nearly 120 million women and girls to access modern contraceptive in middle- and low-income countries. As of 2023, nearly 370 million women were using modern contraceptive, with hormonal methods, such as injectables and orals pills, globally.

Rise in government-led initiatives promoting birth control

  • The surge in initiative by government to promote birth control act as a major driving factor for the growth of the market. Governments are recognizing family planning as a critical public health and socio-economic development tool, globally. According to the United Nations Population Fund (UNFPA), 923 million women of reproductive age (15–49 years) worldwide were using some form of contraception as of 2023, with hormonal methods accounting for over 27% of usage.

Hormonal Contraceptives Market Restraints

Social Resistance and Cultural Stigma

  • In various region such as Middle East, South Asia, and part of Sub-Saharan African, religious conservatism, deep-routed cultural norma and patriarchal structure discourage the use of hormonal contraceptives. Mosty unmarried women and adolescents face stigma and community judgement which limit the access to seek reproductive care and hinder the growth of the market.

Side effect, various health related issue and misinformation about hormonal contraceptive

  • The side effect associated with the use of hormonal contraceptive hinder the growth of the market. The side effect ranges from mood swings to various serious risk such as blood clot. In addition, the spreading of misinformation in social media restrain the market growth.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Hormonal Contraceptives Market size was valued at USD 17.1 Billion in 2023 and is poised to grow from USD 17.8 Billion in 2024 to USD 25.0 Billion by 2032, growing at a CAGR of 4.3% in the forecast period (2025-2032).

To remain competitive in the Hormonal Contraceptives Market, major manufacturers focus on regulatory compliance, product innovation, and expanding access through partnership. The key payers invest in research & development in order to develop advanced formulations such as long-acting injectables which increase production processes to meet the regulatory standard. Acquisition and mergers also drive the market expansion. With the increasing demand for non-oral options among consumers, various companies are diversifying their product portfolio and enhancing their sustainability efforts. 'AbbVie', 'Bayer', 'Pfizer Inc.', 'Merck & Co., Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V. (Viatris Inc.)', 'Allergan plc', 'Johnson & Johnson', 'Agile Therapeutics', 'Organon Group', 'Afaxys, Inc.', 'HRA Pharma', 'Piramal Enterprises Ltd.', 'Novartis AG', 'GlaxoSmithKline plc', 'Dr. Reddy's Laboratories Ltd.', 'Cupid Limited', 'Lupin Pharmaceuticals, Inc.', 'Theramex', 'Evotec SE', ''

The increase in awareness about family planning, coupled with rising female education levels are one of the key factors for the growth of the market. The Family Planning 2030 (FP2030) aims to enable nearly 120 million women and girls to access modern contraceptive in middle- and low-income countries. As of 2023, nearly 370 million women were using modern contraceptive, with hormonal methods, such as injectables and orals pills, globally.

Short-Term: The rapid digital transformation in contraceptive industry with the launch of various app-based prescription services and telemedicine is making hormonal contraceptive user friendly. The increasing demand for convenience and privacy mostly among millennial and Gen Z, the healthcare providers are adopting digital platforms for prescription management, compliance tracking and improve consultancy. These developments are increasing the adherence rate and user satisfaction.

Why is Asia Pacific Leading Hormonal Contraceptives Market in 2024?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Hormonal Contraceptives Market
Hormonal Contraceptives Market

Report ID: SQMIG35I2363

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE